Dogwood Secures FDA IND Nod for SP16 Pain Therapy
Alpharetta, Georgia, U.S. | April 15, 2026 Dogwood Therapeutics has announced a major regulatory milestone with the U.S. Food...
GMP
Advertisement
ARS Pharma Wins Canada Nod for Needle-Free Epinephrine
San Diego, U.S. | April 15, 2026 ARS Pharmaceuticals has achieved a major regulatory milestone with Health Canada approval...
SynOx Phase 3 Study Shows TGCT Treatment Benefit
DUBLIN, IRELAND, April 13, 2026 SynOx Therapeutics has announced positive topline results from its pivotal Phase 3 TANGENT study,...
Novo Nordisk Secures EMA Approval for Wegovy Delivery Flexibility
Bagsværd, Denmark | April 9, 2026 Novo Nordisk has announced that the European Medicines Agency (EMA) has approved an...
BioOra and Octane Expand CAR-T Manufacturing Globally
WELLINGTON, New Zealand & KINGSTON, Canada, April 7, 2026 BioOra Limited and Octane Biotech Inc. announced a strategic Letter...
Advertisements
Co-Diagnostics Expands GMP Facility in Saudi Arabia
SALT LAKE CITY, April 2, 2026 Co-Diagnostics, Inc. announced that its joint venture CoMira Diagnostics has received approval to...
FDA Investigates E. coli Outbreak Linked to Raw Cheese
WASHINGTON, D.C., April 3, 2026 The U.S. Food and Drug Administration (FDA), in collaboration with the Centers for Disease...
GC Biopharma Enhances IVIG Safety with FXI Detection
YONGIN, South Korea, April 6, 2026 GC Biopharma has announced a major advancement in intravenous immunoglobulin (IVIG) safety monitoring...
USDA FSIS Updates Food Safety Policies and Sampling Data
WASHINGTON, D.C., April 3, 2026 The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) has released its...
Quantum BioPharma Submits IND for Lucid-MS Trial
TORONTO, April 1, 2026 Quantum BioPharma Ltd. announced the submission of an Investigational New Drug (IND) application to the...
Advertisement
